Comprehensive Medical Weight Loss
semaglutide, tirzepatide, ozempic, wegovy, zepbound, mounjaro, liraglutide, and saxenda
On February 21st, 2025, the FDA declared that semaglutide (Wegovy / Ozempic) is no longer in shortage. This will have significant impact for patients currently being treated with compounded semaglutide. Read on to learn more about this decision, and about…
FDA Approves Zepbound: A New Hope for Sleep Apnea Relief
On Thursday, 12/19/2024, the FDA declared that tirzepatide (Zepbound / Mounjaro) is no longer in shortage. This will have significant impact for patients currently being treated with compounded tirzepatide. Read on to learn more about this decision, and about your…
Tips to Gracefully Bid Farewell to GLP-1 Meds!
